ArticlePloS one2023

Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo.

Fan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.